Vox Sanguinis · 2009 · 25 citations · 22 references
MedicineCell BiologyHematologyHematology PhysiologyPediatric HematologyStem Cell BiologyHematopoietic Stem Cell BiologyStem Cell MobilizationHematopoietic Stem Cell EvaluationMarrow Reserve AssessmentPeripheral Blood Stem Cell RecoveryPeripheral Blood Stem CellsPositive Predictive ValueSensitivityStem Cell Harvest Timing
BACKGROUND AND OBJECTIVES: Timing of peripheral blood stem cell (PBSC) harvest is typically based on quantification of peripheral blood (PB) CD34+ cells. CD34 enumeration is expensive, requires expertise and takes a minimum of 1-2 h to perform. The Sysmex XE2100 is an automated haematology analyser that can rapidly and inexpensively identify haematopoietic progenitor cell (HPC) populations in PB. The aim of this study was to examine if HPC can be used to optimize timing of PBSC harvest. MATERIALS AND METHODS: White blood cell (WBC), HPC and CD34 counts were determined in a total of 60 mobilized donors. Data were analysed to examine the utility of WBC and HPC counts in predicting preharvest CD34+ counts. RESULTS: In adults presenting for autologous collection, a PB HPC threshold of > 30/microl predicts a preharvest CD34+ count of > 20/microl with sensitivity of 86% and positive predictive value (PPV) of 100%. Among paediatric patients with a diagnosis of neuroblastoma, an HPC threshold of > 16/microl yielded sensitivity and PPV of 100%, while in children with other diagnoses, an HPC cut-off of > 44/microl yielded sensitivity and PPV of 67% and 100%, respectively. Eighty per cent of adequately mobilized allogeneic donors were identified using an HPC threshold > 15/microl, with a PPV of 100%. PB WBC can also aid in predicting CD34 counts in most patient groups, albeit with lower sensitivity than HPC. CONCLUSION: By virtue of being a sensitive and accurate predictor of preharvest CD34+ counts, our data support the use of the HPC parameter in optimizing the timing of PBSC harvest.
22
CD34: structure, biology, and clinical utility [see comments]
Krause Ds, MJ Fackler, CI Civin et al. · Blood · 1996 · 876 citations
CD34: structure, biology, and clinical utility [see comments]
DS Krause, MJ Fackler, CI Civin et al. · Blood · 1996 · 708 citations · Full text
Single platform flow cytometric absolute CD34+ cell counts based on the ISHAGE guidelines
Michael Keeney, Ian Chin‐Yee, Jan Popma et al. · Cytometry · 1998 · 486 citations · Full text
Medicine, Cell Biology, Hematology +16
C. Gregory Elliott, D Samson, S Armitage et al. · Journal of Clinical Oncology · 1996 · 133 citations
Medicine, Hematology, Oncology +17